The Patent Finder

Antibodies That Bind Both IL-17A and IL-17F and Methods of Using the Same

ZymoGenetics Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 12 of these applications claim priority to application 11/684,907, filed Mar 12, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,910,703Antagonists to IL-17A, IL-17F, and IL-23P19 and Methods of Use
In force
 · High confidence
ZymoGenetics, Inc.In force
High confidence
US 8,871,467Polynucleotides Encoding Antibodies That Bind Both IL-17A and IL-17F
In force
 · Low confidence
ZymoGenetics, Inc.In force
Low confidence
US 8,992,922Antagonists of IL-17A, IL-17F, and IL-23P19
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
US 9,416,183Methods of Treating Inflammatory Diseases Using Antibodies That Bind Both IL-17A and IL-17F
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
US 9,464,134Polynucleotides Encoding Antagonists of IL-17A, IL-17F, and IL-23P19
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
US 9,663,572Antibodies That Bind Both IL-17A and IL-17F
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
US 9,994,634Use of an IL-17/IL-23 Bispecific Antibody for Treating Inflammation
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
US 10,000,563Monoclonal Antibodies That Bind Both IL-17A and IL-17F
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
US 10,023,656Methods of Treating Inflammation Using IL-17A and IL-17F Cross-Reactive Monoclonal Antibodies
In force
 · Low confidence
ZymoGenetics, Inc.In force
Low confidence
US 10,562,967Treating Inflammation with IL-17/IL-23 Bispecific Antibodies
In force
 · Medium confidence
ZymoGenetics, Inc.In force
Medium confidence
6 more patents in this group · Pro
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16, including 13 expiring within the 18 months from Nov 15, 2026.
Upgrade to Pro
13 of these are in force and held by ZymoGenetics Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited